180 related articles for article (PubMed ID: 31142321)
1. E2F1 germline copy number variations and melanoma susceptibility.
Rocca MS; Benna C; Mocellin S; Rossi CR; Msaki A; Di Nisio A; Opocher G; Foresta C
J Transl Med; 2019 May; 17(1):181. PubMed ID: 31142321
[TBL] [Abstract][Full Text] [Related]
2. E2F1 copy number variations contribute to spermatogenic impairment and cryptorchidism by increasing susceptibility to heat stress.
Rocca MS; Di Nisio A; Sabovic I; Ghezzi M; Foresta C; Ferlin A
Andrology; 2019 Mar; 7(2):251-256. PubMed ID: 30659775
[TBL] [Abstract][Full Text] [Related]
3. E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women.
Rocca MS; Benna C; Goldin E; Di Nisio A; De Toni L; Cosci I; Marchet A; Nitti D; Foresta C
Mol Med; 2021 Mar; 27(1):26. PubMed ID: 33691613
[TBL] [Abstract][Full Text] [Related]
4. PARKIN Inactivation Links Parkinson's Disease to Melanoma.
Hu HH; Kannengiesser C; Lesage S; André J; Mourah S; Michel L; Descamps V; Basset-Seguin N; Bagot M; Bensussan A; Lebbé C; Deschamps L; Saiag P; Leccia MT; Bressac-de-Paillerets B; Tsalamlal A; Kumar R; Klebe S; Grandchamp B; Andrieu-Abadie N; Thomas L; Brice A; Dumaz N; Soufir N
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26683220
[TBL] [Abstract][Full Text] [Related]
5. Increased gene copy number of the transcription factor E2F1 in malignant melanoma.
Nelson MA; Reynolds SH; Rao UN; Goulet AC; Feng Y; Beas A; Honchak B; Averill J; Lowry DT; Senft JR; Jefferson AM; Johnson RC; Sargent LM
Cancer Biol Ther; 2006 Apr; 5(4):407-12. PubMed ID: 16481740
[TBL] [Abstract][Full Text] [Related]
6. Copy number variations of
Rocca MS; Di Nisio A; Marchiori A; Ghezzi M; Opocher G; Foresta C; Ferlin A
Endocr Relat Cancer; 2017 Mar; 24(3):119-125. PubMed ID: 28104681
[TBL] [Abstract][Full Text] [Related]
7. Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.
Shi J; Zhou W; Zhu B; Hyland PL; Bennett H; Xiao Y; Zhang X; Burke LS; Song L; Hsu CH; Yan C; Chen Q; Meerzaman D; Dagnall CL; Burdette L; Hicks B; Freedman ND; Chanock SJ; Yeager M; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2016 Dec; 136(12):2436-2443. PubMed ID: 27476724
[TBL] [Abstract][Full Text] [Related]
8. Role of rare germline copy number variation in melanoma-prone patients.
Fidalgo F; Rodrigues TC; Silva AG; Facure L; de Sá BC; Duprat JP; Achatz MI; Rosenberg C; Carraro DM; Krepischi AC
Future Oncol; 2016 Jun; 12(11):1345-57. PubMed ID: 27020340
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of ASK/Dbf4 in cutaneous melanoma is dependent on E2F1.
Nambiar S; Mirmohammadsadegh A; Hassan M; Hegemann JH; Hengge UR
Exp Dermatol; 2008 Dec; 17(12):986-91. PubMed ID: 18503552
[TBL] [Abstract][Full Text] [Related]
10. Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia.
Jorgez CJ; Wilken N; Addai JB; Newberg J; Vangapandu HV; Pastuszak AW; Mukherjee S; Rosenfeld JA; Lipshultz LI; Lamb DJ
Fertil Steril; 2015 Jan; 103(1):44-52.e1. PubMed ID: 25439843
[TBL] [Abstract][Full Text] [Related]
11. Copy number variations in malignant melanoma: genomic regions, biomarkers, and therapeutic targets.
Lukáčová E; Pös O; Túryová E; Hurtová T; Hanzlíková Z; Szemes T; Burjanivová T
Neoplasma; 2024 Apr; 71(2):143-152. PubMed ID: 38766854
[TBL] [Abstract][Full Text] [Related]
12. Large germline copy number variations as predisposing factor in childhood neoplasms.
Krepischi AC; Capelli LP; Silva AG; de Araújo ÉS; Pearson PL; Heck B; da Costa CM; de Camargo B; Rosenberg C
Future Oncol; 2014; 10(9):1627-33. PubMed ID: 25145432
[TBL] [Abstract][Full Text] [Related]
13. Contextual role of E2F1 in suppression of melanoma cell motility and invasiveness.
Meng P; Bedolla RG; Yun H; Fitzpatrick JE; Kumar AP; Ghosh R
Mol Carcinog; 2019 Sep; 58(9):1701-1710. PubMed ID: 31124185
[TBL] [Abstract][Full Text] [Related]
14. A germline oncogenic MITF mutation and tumor susceptibility.
Paillerets BB; Lesueur F; Bertolotto C
Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
[TBL] [Abstract][Full Text] [Related]
15. Germline DNA copy number variation in familial and early-onset breast cancer.
Krepischi AC; Achatz MI; Santos EM; Costa SS; Lisboa BC; Brentani H; Santos TM; Gonçalves A; Nóbrega AF; Pearson PL; Vianna-Morgante AM; Carraro DM; Brentani RR; Rosenberg C
Breast Cancer Res; 2012 Feb; 14(1):R24. PubMed ID: 22314128
[TBL] [Abstract][Full Text] [Related]
16. E2F1 in melanoma progression and metastasis.
Alla V; Engelmann D; Niemetz A; Pahnke J; Schmidt A; Kunz M; Emmrich S; Steder M; Koczan D; Pützer BM
J Natl Cancer Inst; 2010 Jan; 102(2):127-33. PubMed ID: 20026813
[TBL] [Abstract][Full Text] [Related]
17. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA copy number in peripheral blood and melanoma risk.
Shen J; Gopalakrishnan V; Lee JE; Fang S; Zhao H
PLoS One; 2015; 10(6):e0131649. PubMed ID: 26110424
[TBL] [Abstract][Full Text] [Related]
19. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
Riverso M; Montagnani V; Stecca B
Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
[TBL] [Abstract][Full Text] [Related]
20. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
